Status:

COMPLETED

Prediction of Outcomes With a Miniaturized Transesophageal Echocardiography Probe in Patients With Acute Respiratory Distress Syndrome

Lead Sponsor:

University Hospital, Lille

Conditions:

Acute Respiratory Distress Syndrome

Eligibility:

All Genders

18+ years

Brief Summary

The Superior Vena cava Respiratory Collapse Index (cVCS) is a haemodynamic parameter measured exclusively by transoesophageal ultrasound (TEE), which is used to assess cardiac precharge-dependence sta...

Eligibility Criteria

Inclusion

  • Patients hospitalized in Resuscitation, Emergency or Intensive Care Units at the Roger Salengro Hospital at Lille University Hospital.
  • With acute respiratory distress syndrome of intermediate or severe severity (1) for less than 24 hours.
  • Mechanical ventilation with tracheal intubation or tracheostomy, in controlled assisted ventilation (VAC) mode.
  • Patient adapted to mechanical ventilation (no triggering of spontaneous ventilation cycle in VAC mode verified by the equality between the respiratory rate prescribed on the ventilator and the actual respiratory rate of the patient).

Exclusion

  • Patient under extracorporeal respiratory assistance at the time of inclusion.
  • Anomalies or pathologies that make it dangerous or impossible to introduce an ETO probe:
  • Fistula, perforation, stenosis, varicose vein or diverticulum of the esophagus and / or stomach
  • History of esophageal and / or gastric surgery
  • Caustic lesions of the esophagus and / stomach
  • Tumor or history of oropharyngeal surgery
  • Unstable lesions of the cervical spine
  • Coagulopathy (thrombocytopenia \<50 109 / L and / or TP \<50%).
  • Impossibility of measuring the diameter of the superior vena cava and cVCS in ETO due to poor echogenicity.
  • Pregnant woman.
  • Therapeutic limitation measures limiting the treatment of organ failure.

Key Trial Info

Start Date :

April 21 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 20 2021

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT03763773

Start Date

April 21 2019

End Date

April 20 2021

Last Update

April 29 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hôpital Roger Salengro, CHU

Lille, France